Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetic in Normal Population”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04544189
What this trial is testing

Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer

Who this might be right for
Breast Neoplasms
Novartis Pharmaceuticals 69
Very early researchNot Yet RecruitingNCT07373743
What this trial is testing

Pharmacokinetic (PK) Study of Tafenoquine in Healthy Adults

Who this might be right for
Pharmacokinetic in Normal Population
State University of New York - Upstate Medical University 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06290375
What this trial is testing

HSK21542 in a Peritoneal Dialysis Pruritus Population.

Who this might be right for
Pruritus
Xizang Haisco Pharmaceutical Co., Ltd 250
Early research (Phase 1)Study completedNCT00054483
What this trial is testing

Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+31 more
National Cancer Institute (NCI) 69
Early research (Phase 1)Study completedNCT06126575
What this trial is testing

A PK Study Testing Single Oral Dose of Elacestrant in Subjects With Normal or Severely Impaired Hepatic Function

Who this might be right for
Hepatic Impairment
Stemline Therapeutics, Inc. 16
Early research (Phase 1)Ended earlyNCT04136444
What this trial is testing

A Pharmacokinetic Study of Padsevonil in Study Participants With Either Normal or Moderately Impaired Hepatic Function

Who this might be right for
Healthy Study ParticipantsImpaired Hepatic Function
UCB Biopharma S.P.R.L. 12
Large-scale testing (Phase 3)WithdrawnNCT04680962
What this trial is testing

MabionCD20® Compared to MabThera® and Rituxan® in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Mabion SA
Early research (Phase 1)Study completedNCT04656795
What this trial is testing

PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function

Who this might be right for
Renal ImpairmentNormal Renal Function
Tanabe Pharma America, Inc. 32
Not applicableLooking for participantsNCT06993636
What this trial is testing

Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years

Who this might be right for
Kawasaki DiseaseCoronary Artery AneurysmRivaroxaban+2 more
Children's Hospital of Fudan University 60
Early research (Phase 1)Study completedNCT01861509
What this trial is testing

BP-C1 in Metastatic Breast Cancer Patients

Who this might be right for
Metastatic Breast CancerStage IV Breast Cancer
Meabco A/S 10
Early research (Phase 1)Study completedNCT00927407
What this trial is testing

Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head Lice

Who this might be right for
Pediculosis
Sun Pharmaceutical Industries, Inc. 24
Early research (Phase 1)Study completedNCT00508768
What this trial is testing

Oral SCIO-469 Pharmacokinetics (Study of a Drug in the Body to Watch How the Drug is Absorbed, Distributed, Metabolized and Eliminated Over a Period of Time) in the Body of Female Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Scios, Inc. 16
Early research (Phase 1)Study completedNCT03025841
What this trial is testing

Population Pharmacokinetic (PK) Study of Zinforo (Ceftaroline) in Critical Care Patients With Early-onset Pneumonia and Normal or Augmented Renal Clearance

Who this might be right for
Pneumonia
Poitiers University Hospital 18
Early research (Phase 1)Study completedNCT01026558
What this trial is testing

A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients

Who this might be right for
ObesityStaphylococcal Skin InfectionsStreptococcal Infections
Basilea Pharmaceutica 25
Early research (Phase 1)Study completedNCT03009162
What this trial is testing

Study of Oral Lasmiditan in Participants With Normal and Impaired Renal Function

Who this might be right for
Migraine
Eli Lilly and Company 16
Testing effectiveness (Phase 2)Study completedNCT02805725
What this trial is testing

Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic Cyclophosphamide

Who this might be right for
Soft-tissue Sarcomas
Institut Bergonié 50
Early research (Phase 1)Study completedNCT00750620
What this trial is testing

A Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Impairment
Astellas Pharma Inc 33
Early research (Phase 1)Study completedNCT05471648
What this trial is testing

A Pharmacokinetic Study Comparing EG1206A and Perjeta (Pertzumab) in Healthy Male Volunteers

Who this might be right for
Breast Cancer
EirGenix, Inc. 135
Testing effectiveness (Phase 2)Study completedNCT04204603
What this trial is testing

A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Chong Kun Dang Pharmaceutical 122
Early research (Phase 1)Study completedNCT01513083
What this trial is testing

Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function

Who this might be right for
Breast Cancer
Hoffmann-La Roche 28
Load More Results